Table 1.
442 nm band (Fe2+) | Ksa (nM) | Eo,7b (mV) | kfastc (s−1) | Tmd (°C) | IC50e (nM) | |
---|---|---|---|---|---|---|
ritonavir | +f | 51 ± 10f | −350 ± 5f | 1.4 ± 0.3f | 54.8 ± 0.1 | 550 ± 50 |
1 | − | 22 ± 4 | <<-370 | 1.9 ± 0.3 | 56.5 ± 0.2 | 280 ± 40 |
2 | ± | 570 ± 30 | ≈ −370 | 2.2 ± 0.4 | 54.8 ± 0.1 | 3400 ± 60 |
3 | + | 25 ± 5 | −350 ± 5 | 7.0 ± 0.5 | 57.2 ± 0.2 | 130 ± 15 |
Spectral dissociation constant.
Midpoint redox potential of the inhibitor-bound CYP3A4. Eo,7 of the ligand-free CYP3A4 is ~−300 mV.7
Rate constant of the fast phase of the ligand binding reaction.
Melting temperature of the CYP3A4-inhibitor complex. Tm for the ligand-free CYP3A4 in the absence and presence of 2% DMSO is 52.6 ± 0.1 and 52.1 ± 0.1 °C, respectively.
Concentration required for half-maximal inactivation of recombinant CYP3A4.
Determined previously.7